Single high-dose intravenous injection of Wharton's jelly-derived mesenchymal stem cell exerts protective effects in a rat model of metabolic syndrome.

Alvin Man Lung ChanAngela Min Hwei NgMohd Heikal Mohd YunusRuszymah Hj IdrusJia Xian LawMuhammad Dain YazidKok-Yong ChinMohd Rafizul Mohd YusofSee Nguan NgBenson KohYogeswaran Lokanathan

Published in: Stem cell research & therapy (2024)

The establishment of safety and therapeutic proof-of-concept encourages further studies by improving the current therapeutic model.

Keyphrases

high dose
metabolic syndrome
mesenchymal stem cells
umbilical cord
low dose
stem cell transplantation
type diabetes
ultrasound guided
cell therapy